| Vol. 11.24 – 27 June, 2023 |
| |
|
|
| To better understand the role of dedicator of cytokinesis 11 (DOCK11) in human immune-cell function and disease, scientists conducted genetic, immunologic, and molecular assays in four patients from four unrelated families. [New England Journal Of Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators showed a comprehensive interactome of NBEAL2 in primary T cells, based on mass spectrometry identification of altogether 74 protein association partners. [Nature Communications] |
|
|
|
| Researchers showed that two key pathways in T cell signaling, calcium/nuclear factor of activated T cells (NFAT) and protein kinase C/nuclear factor κB (NF-κB), integrated through a dynamic and combinatorial strategy to fine-tune T cell response genes. [Cell Reports] |
|
|
|
| Cells from young and older adults were used to evaluate the effect of novel biomaterials on cytokine and chemokine secretion in comparison to standard immune activators such as lipopolysaccharide and PMA/ionomycin. [Immunity & Ageing] |
|
|
|
| Researchers determined whether pathogenic neutrophil extracellular traps in anti-neutrophil cytoplasmic antibody-associated vasculitis escape from efferocytosis via the CD47 signaling pathway, resulting in the development of necrotizing vasculitis. [JCI Insight] |
|
|
|
| The authors demonstrated that STAT1 gain-of-function human ex-vivo peripheral blood neutrophils were immature and highly activated; had strong propensity for degranulation, NETosis, and platelet-neutrophil aggregation; and displayed marked inflammatory bias. [Journal of Clinical Immunology] |
|
|
|
| Scientists expanded IL-17A+ CD8+ T cells from healthy donor peripheral blood mononuclear cell or bulk CD8+ T cell populations using an in vitro polarization protocol. [Clinical and Experimental Immunology] |
|
|
|
| Principal component analysis of Raman spectra from neutrophil extracellular traps clearly distinguished them from necrotic cells despite their similar morphology, demonstrating their fundamental molecular differences. [Scientific Reports] |
|
|
|
| Scientists tested whether the blockade of programmed cell-death-1 (PD-1) and/or lymphocyte-activation-gene-3 (LAG-3) could enhance invariant Natural Killer T (iNKT) cell function. Utilizing peripheral blood mononuclear cells from healthy donors, they assessed the LAG-3 and PD-1 expression on iNKT cells. [Scientific Reports] |
|
|
|
|
| The authors provide a brief history of the field and summarize the biology of circulating and tissue-resident memory CD8+ T cells, which are ultimately responsible for effective immune surveillance. [Nature Immunology] |
|
|
|
| Scientists provide and critically discuss recent evidence for different aspects associated with optimal immune responses required for the design of effective whole-tumor cell vaccines. [British Journal Of Cancer] |
|
|
|
|
| ImmunoGenesis announced that Cancer Focus Fund plans to invest $4.5 million to support the Phase Ia/Ib clinical trial of ImmunoGenesis’ lead candidate, IMGS-001. [ImmunoGenesis (PRNewswire)] |
|
|
|
|
| July 16 – 21, 2023 Holderness, New Hampshire, United States |
|
|
|
|
|
| University of Alabama at Birmingham – Birmingham, Alabama, United States |
|
|
|
| University of Tübingen – Tübingen, Germany |
|
|
|
| Brigham and Women’s Hospital – Boston, Massachusetts, United States |
|
|
|
| University of Miami – Miami, Florida, United States |
|
|
|
| VIB Center for Cancer Biology – Leuven, Belgium |
|
|
|
|